{"symbol": "INFI", "companyName": "Infinity Pharmaceuticals Inc.", "exchange": "Nasdaq Global Select", "industry": "Biotechnology", "website": "http://www.infi.com", "description": "Infinity Pharmaceuticals Inc is a biopharmaceutical company focused on developing novel medicines for the treatment of specific cancers. It is focused on advancing IPI-549, an orally administered, clinical-stage, immuno-oncology product candidate.", "CEO": "Adelene Q. Perkins", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}